74. EPMO Open Source Coordination Office Redaction File Detail Report

Produced by Araxis Merge on 11/9/2017 4:31:05 PM Central Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.

74.1 Files compared

# Location File Last Modified
1 PPS-N_B397.zip\PPS-N_B397\PPS-N_B397\PS_PPS_ui\src\test\resources\messages duplicateTherapyBugResponse.xml Thu Nov 9 15:03:06 2017 UTC
2 PPS-N_B397.zip\PPS-N_B397\PPS-N_B397\PS_PPS_ui\src\test\resources\messages duplicateTherapyBugResponse.xml Thu Nov 9 21:18:05 2017 UTC

74.2 Comparison summary

Description Between
Files 1 and 2
Text Blocks Lines
Unchanged 3 230
Changed 2 4
Inserted 0 0
Removed 0 0

74.3 Comparison options

Whitespace
Character case Differences in character case are significant
Line endings Differences in line endings (CR and LF characters) are ignored
CR/LF characters Not shown in the comparison detail

74.4 Active regular expressions

No regular expressions were active.

74.5 Comparison detail

  1   <?xml 
  2     version="1 .0" 
  3     encoding=" UTF-8"
  4   ?>
  5   <PEPSRespo nse
  6       
  7     xsi:schema Location=" gov/va/med /pharmacy/ peps/exter nal/common /preencaps ulation/vo /drug/chec k/response  drugCheck SchemaOutp ut.xsd"
  8       
  9     xmlns:xsi= "http://ww w.w3.org/2 001/XMLSch ema-instan ce" 
  10     xmlns="gov /va/med/ph armacy/pep s/external /common/pr eencapsula tion/vo/dr ug/check/r esponse"
  11   >
  12         
  13     <Header>
  14              
  15      <Time 
  16       value="084 5"
  17      />
  18              
  19      <MServer 
  20       namespace= "VISTA" 
  21       uci="text"  
  22       ip=" IP          "
  23                   
  24       serverName ="Server N ame" 
  25       stationNum ber="45"
  26      />
  27              
  28      <MUser 
  29       userName=" REDACTED
  30       duz="88660 079" 
  31       jobNumber= "1002"
  32      />
  33              
  34      <PEPSVersi on 
  35       difIssueDa te="200810 20" 
  36       difBuildVe rsion="6" 
  37       difDbVersi on="3.2"
  38      />
  39          
  40     </Header>
  41         
  42     <Body>
  43              
  44      <drugCheck >
  45                    
  46       <drugThera pyChecks>
  47                         
  48        <drugThera pyCheck>
  49                              
  50         <interacte dDrugList>
  51                                    
  52          <drug 
  53           orderNumbe r="Z;2;Pro spect" 
  54           ien="93268
  55           gcnSeqNo=" 24538"
  56          />
  57                                    
  58          <drug 
  59           orderNumbe r="Z;1;Pro spect" 
  60           ien="344" 
  61           gcnSeqNo=" 58432"
  62          />
  63                               
  64         </interact edDrugList >
  65                              
  66         <classific ation>
  67          Calcium Ch annel Bloc kers
  68         </classifi cation>
  69                              
  70         <duplicate Allowance>
  71          0
  72         </duplicat eAllowance >
  73                              
  74         <shortText >
  75          Use of DIL TIAZEM HCL  ORAL CAPS ULE,SUSTAI NED ACTION  240 MG an d AMLODIPI NE BESYLAT E/ATORVAST ATIN CALCI UM ORAL TA BLET 2.5 M G-10 MG ma y represen t a duplic ation in t herapy bas ed on thei r associat ion to the  therapeut ic drug cl ass Calciu m Channel  Blockers.
  76         </shortTex t>
  77                          
  78        </drugTher apyCheck>
  79                         
  80        <drugThera pyCheck>
  81                              
  82         <interacte dDrugList>
  83                                    
  84          <drug 
  85           orderNumbe r="Z;2;Pro spect" 
  86           ien="93267
  87           gcnSeqNo=" 16579"
  88          />
  89                                    
  90          <drug 
  91           orderNumbe r="Z;1;Pro spect" 
  92           ien="344" 
  93           gcnSeqNo=" 58432"
  94          />
  95                               
  96         </interact edDrugList >
  97                              
  98         <classific ation>
  99          HMGCo-A Re ductase In hibitors
  100         </classifi cation>
  101                              
  102         <duplicate Allowance>
  103          0
  104         </duplicat eAllowance >
  105                              
  106         <shortText >
  107          Use of SIM VASTATIN O RAL TABLET  40 MG and  AMLODIPIN E BESYLATE /ATORVASTA TIN CALCIU M ORAL TAB LET 2.5 MG -10 MG may  represent  a duplica tion in th erapy base d on their  associati on to the  therapeuti c drug cla ss HMGCo-A  Reductase  Inhibitor s.
  108         </shortTex t>
  109                          
  110        </drugTher apyCheck>
  111                     
  112       </drugTher apyChecks>
  113               
  114      </drugChec k>
  115          
  116     </Body>
  117   </PEPSResp onse>